Clinical TrialID 6903
Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme
NCT00540722
Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain Tumor
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 6903
- Evidence Id
- 6903
- Core Evidence Id
- 6903
- Source Clinical Trial Id
- 6895
- Herb2 Clinical Trial Id
- HBCT006895
- Nct Id
- NCT00540722
- Title
- Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme
- Status
- Completed
- Phase
- Phase 2
- Study Result
- Yes
- Study Condition
- Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain Tumor
- Study Type
- Interventional
- Study Design
- Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
- Intervention
- DRUG: R-(-)-gossypol acetic acid|OTHER: laboratory biomarker analysis
- Intervention Allocation
- Intervention Model
- Single_Group
- Intervention Mask
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Adult, Older_Adult
- Enrollment
- 56
- Outcome Measure
- Overall Survival, The overall failure rate will be estimated along with 95% confidence intervals. A median time of survival will be estimated using standard methods., 4.5 years
- Sponsor Collaborator
- National Cancer Institute (NCI)
- Funded By
- NIH
- Location
- University of Alabama at Birmingham, Birmingham, Alabama, 35294, United States|Moffitt Cancer Center, Tampa, Florida, 33612, United States|Johns Hopkins University, Baltimore, Maryland, 21287, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Henry Ford Hospital, Detroit, Michigan, 48202, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, 27157, United States|Cleveland Clinic Foundation, Cleveland, Ohio, 44195, United States|University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States
- Other Id
- NCI-2013-00018|0702|CDR0000569405|ABTC-0702|NABTT 0702|U01CA062475
- Start Date
- 2008-01
- Primary Completion Date
- 2012-06
- Completion Date
- 2012-06
- First Posted
- 2007-10-08
- Results First Posted
- 2017-07-12
- Last Update Posted
- 2017-08-11
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT00540722
- Title Cn
- Title En
- Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme
- Bilingual Status
- semi_complete